David L. Huso

Active 1998–2021

73
Papers
18,724
Citations
71
h-index
73
i10-index

Citations

Citations per year for David L. Huso1986: 1 citations1998: 1 citations1999: 9 citations2000: 21 citations2001: 30 citations2002: 44 citations2003: 49 citations2004: 74 citations2005: 96 citations2006: 148 citations2007: 168 citations2008: 201 citations2009: 216 citations2010: 277 citations2011: 269 citations2012: 223 citations2013: 227 citations2014: 244 citations2015: 208 citations2016: 247 citations2017: 212 citations2018: 277 citations2019: 748 citations2020: 721 citations2021: 752 citations2022: 658 citations2023: 455 citations2024: 664 citations2025: 339 citations2026: 21 citations1987–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,897 citing papers, 32.5% of this breakdownChina: 1,275 citing papers, 14.3% of this breakdownUnited Kingdom: 511 citing papers, 5.7% of this breakdownGermany: 422 citing papers, 4.7% of this breakdownItaly: 332 citing papers, 3.7% of this breakdownFrance: 295 citing papers, 3.3% of this breakdownCanada: 277 citing papers, 3.1% of this breakdownJapan: 256 citing papers, 2.9% of this breakdownNetherlands: 194 citing papers, 2.2% of this breakdownAustralia: 176 citing papers, 2% of this breakdownSpain: 170 citing papers, 1.9% of this breakdownSouth Korea: 156 citing papers, 1.7% of this breakdown
0%32.5%Other 22%

Fields

  • Biochemistry, Genetics and Molecular Biology56.7%
  • Medicine31.9%
  • Immunology and Microbiology5.3%
  • Neuroscience1.7%
  • Engineering0.8%
  • Nursing0.8%
  • Other2.8%

Topics

  • Gut microbiota and health6.9%
  • Cancer Research and Treatments3.1%
  • Connective tissue disorders research2.2%
  • Clostridium difficile and Clostridium perfringens research2%
  • Aortic Disease and Treatment Approaches1.8%
  • Cancer, Hypoxia, and Metabolism1.6%
  • Other82.4%

Coauthors

All papers

Open in search
  1. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria

    Authors: , , , , , , , , , , , , , , , , , - Science 2018 cited by 1,140

  2. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses

    Authors: , , , , , , , , , , , , - Nature Medicine 2009 cited by 1,784

  3. Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cell Host & Microbe 2018 cited by 635

  4. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis -induced colon tumorigenesis

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 cited by 597

  5. Intratumoral injection of Clostridium novyi -NT spores induces antitumor responses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Chetan Bettegowda, David L. Huso, Mary Varterasian, Saurabh Saha, Shibin Zhou - Science Translational Medicine 2014 cited by 395

  6. Combination bacteriolytic therapy for the treatment of experimental tumors

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 562

  7. Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , - Science 2006 cited by 1,797

  8. Mutant PIK3CA promotes cell growth and invasion of human cancer cells

    Authors: , , , , , , , , , , , - Cancer Cell 2005 cited by 919

  9. Regulatory T-cell Response to Enterotoxigenic Bacteroides fragilis Colonization Triggers IL17-Dependent Colon Carcinogenesis

    Authors: , , , , , , , , - Cancer Discovery 2015 cited by 192

  10. Bacteriolytic therapy can generate a potent immune response against experimental tumors

    Authors: , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2004 cited by 299

  11. Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome

    Authors: , , , , , , , - Journal of Clinical Investigation 2004 cited by 396

  12. Induction of Persistent Colitis by a Human Commensal, EnterotoxigenicBacteroides fragilis, in Wild-Type C57BL/6 Mice

    Authors: , , , , , , , , , , , , , , , - Infection and Immunity 2009 cited by 287

  13. Angiotensin II–dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2013 cited by 250

  14. Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria

    Authors: , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 169

  15. Stat3 Activation in Murine Colitis Induced by Enterotoxigenic Bacteroides fragilis

    Authors: , , , , , , , , , , , - Inflammatory Bowel Diseases 2014 cited by 116

  16. A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome

    Authors: , , , , , , , , , , , , , , , , , , , - eLife 2015 cited by 117

  17. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α

    Authors: , , , , , , , , , , - Journal of Clinical Investigation 1999 cited by 655

  18. A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1

    Authors: , , , , - Nature Medicine 2007 cited by 421

  19. Short Telomeres, even in the Presence of Telomerase, Limit Tissue Renewal Capacity

    Authors: , , , , , , - Cell 2005 cited by 307

  20. Radioimmunotherapy of Breast Cancer Metastases with α-Particle Emitter 225Ac: Comparing Efficacy with 213Bi and 90Y

    Authors: , , , , , , , - Cancer Research 2009 cited by 156

  21. Enterotoxigenic Bacteroides fragilis: A potential instigator of colitis

    Authors: , , , , , , , , - Inflammatory Bowel Diseases 2007 cited by 146

  22. Pharmacologic and Toxicologic Evaluation of C. novyi-NT Spores

    Authors: , , , , , , , , , , , , , , , , , , , , , - Toxicological Sciences 2005 cited by 116

  23. G-protein coupled receptor 35 (GPR35) regulates the colonic epithelial cell response to enterotoxigenic Bacteroides fragilis

    Authors: , , , , , , , , , , , , , , - Communications Biology 2021 cited by 46

  24. P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 433